Amplifying Your Precision Medicine Strategy: The role of Engagement Experts and Peer Networks
Sarah Heming
How can multi-modal communications and peer-to-peer engagement elevate your diagnostic commercialization strategy?
In this Q&A, we share insights on how these approaches can amplify your precision medicine strategy, enhance diagnostic commercialization, and ensure your message effectively reaches the right audience.
Q1 How does incorporating multi-modal communications enhance your diagnostic commercialization strategy?
By utilizing different modes of communication and by leveraging the available messengers i.e. the pathologists, your precision medicine story is maximized and amplified driving overall brand success.
Q2 How would access to our Precision Medicine Engagement Experts increase your team's ability to deliver messaging about the importance of testing?
Tapping into the right message is critical for marketing success. Utilizing the right messenger is equally important. Our Precision Medicine Engagement Experts have spent decades in the laboratory. They speak the language and have the battle scars consistent with your audience giving them a unique perspective and unique skills to deliver messaging on your biomarker needs, from a laboratorians perspective.
Q3 Why is stakeholder engagement at a peer to peer level crucial for the success of precision medicine testing?
Addresses a known practice gap, brings confidence, Collaborative and more efficient working at tumor boards to ensure a patient get access to the best therapy options. Raising your engagements to a peer-to-peer level delivers a heightened degree of importance. This model increase access and delivers your content at the level of your audience, practicing physician to practicing physician.
Q4 What advantages does our DXRX Expert Exchange solution offer in expanding and promoting test awareness?
Biomarker testing does not occur in a vacuum. There are a number of additional factors that HCPs deal with long after your field teams leave the office. When your message is delivered by someone who deals with the same challenges day in and day out, there is a level of understanding and acceptance that occurs that otherwise is missed in a standard field engagement. Expert Exchange adds significant weight to your biomarker messaging.
About Diaceutics
At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome.
We provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX – The Diagnostics Network ®
How does multi-modal communication improve precision medicine commercialization?
Using different communication formats alongside the right messengers, such as pathologists, helps amplify a precision medicine story and maximize its reach. This multi-channel approach ensures the message resonates across different touchpoints, driving stronger overall brand success.
Why do peer-to-peer engagement experts improve HCP messaging on biomarker testing?
Peer-to-peer engagement experts with decades of laboratory experience speak the same language as their audience and understand the practical realities of biomarker testing firsthand. This laboratorian's perspective gives them a unique ability to deliver credible, relevant messaging that resonates with practicing physicians.
Why is peer-to-peer stakeholder engagement important for precision medicine testing success?
Peer-to-peer engagement addresses known practice gaps and builds confidence among physicians, encouraging more collaborative and efficient decision-making at tumor boards. Delivering content physician-to-physician, rather than through traditional field teams, increases both the credibility and the accessibility of the message.
What is DXRX Expert Exchange and how does it support biomarker test awareness?
DXRX Expert Exchange is Diaceutics' peer-to-peer engagement solution that connects HCPs with experts who understand the day-to-day realities of biomarker testing beyond the initial field visit. This ongoing, credible support helps address practical testing challenges that standard field engagement often misses, adding significant weight to biomarker messaging.
What role do Precision Medicine Engagement Experts play in diagnostic commercialization?
Precision Medicine Engagement Experts bring decades of hands-on laboratory experience, giving them the technical fluency and credibility needed to communicate biomarker testing needs effectively. Their unique perspective helps commercial teams deliver messaging that lands with the same authority as a trusted colleague.
How can biopharma teams accelerate precision medicine uptake through scientific engagement?
Written By Sarah Heming
Newsletter sign up
READY TO DO COMMERCIALIZATION DIFFERENTLY?
You might also be interested in?
Redefining HCP Engagement with Clinical, Behavioral & Companion Diagnostics
Transform HCP engagement by integrating clinical, behavioral, and companion diagnostics data for precise targeting and improved outreach effectiveness. Discover the future of pharma marketing.